Combination of calcium channel blockers and beta blockers for patients with exercise-induced angina pectoris: A double-blind parallel-group comparison of different classes of calcium channel blockers

Angiology

Volumn 50, Issue 6, 1999, Pages 447-454

  Van Der Vring, J A F M ^a   Daniels M C G ^a   Holwerda, N J H ^a   Withagen, P J A M ^a   Schelling, A ^a   Cleophas, T J ^a   Hendriks, M G C ^a  

^a Merwede Ziekenhuis   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; MIBEFRADIL;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; BLOOD PRESSURE; CHRONOTROPISM; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT DEPRESSION; TREATMENT OUTCOME; VERTIGO;

EID: 0344223329     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/000331979905000602     Document Type: Article

References (17)

1. Dunselman PH, Liem AH, Verdel G, et al: Addition of felodipine to metoprolol vs replacement of metoprolol by felodipine in patients with angina pectoris despite adequate beta blockade. Eur Heart J 18: 1755-1764, 1997.
2. Dibianco R, Schoonmaker FW, Singh JB, et al: Amlodipine combined with beta blockade for chronic angina: Results of a multicenter, placebo-controlled, randomized, double-blind study. Clin Cardiol 15: 519-524, 1992.
3. Dunselman PH, Van Kempen LH, Bouwens LH, et al: Value of the addition of amlodipine to atenolol in patients with angina pectoris despite adequate beta blockade. Am J Cardiol 81:128-132, 1998.
4. Kawanishi DT, Reid CL, Morrison EC, et al: Response of angina and ischemia to long-term treatment in patients with chronic stable angina: A double-blind, randomized, individualized dosing trial of nifedipine, propranolol, and their combination. J Am Coll Cardiol 19:409-417, 1992.
5. De vries RJ, Dunselman PH, Van Veldhuisen DJ, et al: Comparison between felodipine and isosorbide mononitrate as adjunct to beta blockade in patients >65 years of age with angina pectoris. Am J Cardiol 74:1201-1206, 1994.
6. Hill JA, Gonzalez JI, Kolb R, et al: Effects of atenolol alone, nifedipine alone, and their combination on ambulant and exercise-induced myocardial ischemia. Am J Cardiol 67:671-675, 1991.
7. Davies RF, Habibi H, Klinke WP, et al: Effect of amlodipine, atenolol, and their combination on myocardial ischemia during treadmill exercise and ambulatory monitoring. J Am Coll Cardiol 25:619-625, 1995.
8. Deanfield JE, Detry JM, Lichtlen PR, et al, for the CAPE Study Group: Amlodipine reduces transient myocardial ischemia in patients with coronary artery disease: A double-blind circadian anti-ischemia program in Europe. J Am Coll Cardiol 24:1460-1467, 1994.
9. Akhras F, Jackson G: Efficacy of nifedipine and isosorbide mononitrate in combination with atenolol in stable angina pectoris. Lancet 338:1036-1039, 1991.
10. Fox KM, Mulcahy D, Findlay I, et al, on behalf of the TIBET Study Group: Effects of atenolol, nifedipine SR, and their combination on the exercise test and the total ischemic burden in 608 patients with stable angina pectoris. Eur Heart J 17:96-103, 1996.
11. Opie LH, Frishman WH, Thadani U: Calcium channel antagonists. In: Drugs for the Heart, ed. 4, ed. by Opie LH. Philadelphia: WB Saunders, 1995, pp 50-82.
12. Abenethy DR: Pharmacologic and pharmacokinetic profile of mibefradil, a T-type and L-type calcium channel antagonist. Am J Cardiol 80(4B):4-11, 1997.
13. Morse JR: Comparison of combination nifedipine-propranolol and diltiazem-propranolol with high-dose diltiazem monotherapy for stable angina pectoris. Am J Cardiol 62:1028-1032, 1988.
14. Siu SC, Jacoby RM, Phillips RT, et al: Comparative efficacy of nifedipine GITS (gastrointestinal therapeutic system) versus diltiazem when added to beta blockers in stable angina pectoris. Am J Cardiol 71: 887-892, 1993.
15. The World Medical Association, Inc: World Medical Association Declaration of Helsinki, as amended by the 41st World Assembly, Hong Kong, September 1989. Ferney-Voltaire, France, September 1989: 17c, pp 1-2.
16. Drug interactions with Roche's Posicor to restrict market. Scrip, November 24, 1997.
17. Vaghy PL: Calcium antagonists. In: Human Pharmacology, ed. by Brody TM, Larner J, Minneman KP, et al. New York: Mosby, 1994, pp 203-215.